NASDAQ · Medical - Healthcare Information Services

SCNX (SCNX) Stock

$0.37 -0.60% NASDAQ: SCNX Healthcare

Valuation

MetricValue
Price$0.37
Market Cap$5.66M
P/E Ratio-0.16
P/B Ratio0.09
P/S Ratio12.54
EPS (TTM)$-2.70
52-Week High$2.60
52-Week Low$0.24
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-0.25%
ROA-0.05%
ROCE-0.02%
Gross Margin95.48%
Operating Margin-27.19%
Net Margin-73.75%
Debt/Equity0.00
Current Ratio2.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$10.0M$1.0M$0$0
Operating Profit$-5.0M$-3.0M$-4.0M$-15.0M$-16.0M
Net Profit$-5.0M$-3.0M$-18.0M$9.0M$-42.0M
EPS$-9.80$-6.15$-7.49$2.48$-2.70
Op Margin-53.5%-28.4%-322.4%-10758.7%-3763.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.0M$4.0M$13.0M$105.0M$84.0M
Total Liabilities$2.0M$3.0M$12.0M$26.0M$14.0M
Cash$3.0M$1.0M$0$0$7.0M
Borrowings$1.0M$2.0M$7.0M$4.0M$0

Latest News

SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers GlobeNewswire · Jul 9, 2026 SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide GlobeNewswire · Jun 18, 2026 SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team GlobeNewswire · Jun 9, 2026 EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch Benzinga · Jun 9, 2026 SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC ACCESS Newswire · Jun 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-2.0M$-2.0M$-14.0M$-13.4B
Investing Cash Flow$0$-1.0M$0$28.0M$0
Financing Cash Flow$0$0$1.0M$-1.0M$19.7B
Net Cash Flow$-3.0M$-2.0M$-1.0M$0$6.4B
Free Cash Flow$-3.0M$-2.0M$-2.0M$-14.0M$-13.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA89.40
FCF Yield-222.74%
Quick Ratio1.63
Interest Coverage-4.69
Return 1Y-76.14%
Return 3Y-93.74%
Return 5Y-99.14%

Ownership

Insiders Held13.31%
Institutions Held3.87%
Institutions Float Held4.46%
Institutional HolderSharesReport Date
Geode Capital Management, LLC432,1862026-03-31
Vanguard Capital Management LLC408,0912026-03-31
Vanguard Fiduciary Trust Co198,0602026-03-31
UBS Group AG107,8332026-03-31
Virtu Financial LLC84,2112026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AEONAEON Biopharma, Inc. $0.24 -5.50% -0.05 $2.80M 0.00%
BFRG $0.61 +4.04% -1.00 $7.11M 0.00%
BOLT $3.95 -0.50% -0.26 $7.59M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%
EVGNEvogene Ltd. $0.54 -0.04% -0.41 $4.67M 0.00%

About SCNX

SCNX is led by CEO Shankar Hariharan, employs 14 people, headquartered in US, publicly traded since 2014.

SCNX stock trades at $0.37 with a market capitalization of $5.66M. The stock is valued at a price-to-earnings (P/E) ratio of -0.16, price-to-book of 0.09, price-to-sales of 12.54. Over the past 52 weeks the stock has ranged between $0.24 and $2.60, and currently trades 85.8% below its 52-week high.

On profitability, SCNX generates a return on equity (ROE) of -0.25%, return on capital employed of -0.02%, an operating margin of -27.19%, a net profit margin of -73.75%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides